Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
OrphanDC: We're all about connecting Patients to Orphan Drugs Novel Therapies and Clinical Trials
São Paulo, Brazil
C
11-50 Employees
2016
Key takeaway
The company focuses on providing clinical trial treatments and access for patients with rare and complex conditions in Latin America, which may include innovative therapies like CAR-T cell therapy.
Reference
Service
OrphanDC | Services
River City Biotecnologia
Luziânia, Brazil
C
11-50 Employees
2014
Key takeaway
River City Biotecnologia Brazil is a key player in the cell culture industry, which is essential for the development of therapies like CAR-T cell therapy. Their commitment to maintaining detailed records of traceability for serum batches underscores their dedication to quality and compliance in biotechnological processes.
Reference
Core business
Home | River City Biotecnologia
OTAWA Health
São Paulo, Brazil
C
1-10 Employees
2019
Key takeaway
OTAWA Health is revolutionizing oncology care with its Advanced Digital Oncology platform, which enhances the management and treatment of cancer through innovative solutions and structured Real-World Data. This approach aims to improve outcomes for patients with cancer by providing tools for better care coordination and decision-making.
Reference
Core business
Otawa Health – A DIGITAL ONCOLOGY platform made of a specialized oncology-EHR/CDS solution created BY and FOR cancer care professionals. OTAWA Health contributes to better management of cancer centers enabling a comprehensive and coordinated care while collecting structured oncology Real-World Data for Real-World Evidence studies to improve outcomes for patients with cancer.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
CarrierWeb
Rio de Janeiro, Brazil
C
51-100 Employees
2002
Key takeaway
CarrierWeb, now part of PowerFleet, is involved in innovative healthcare solutions.
Reference
Core business
CarrierWeb USA
BioShield Ltda
São Paulo, Brazil
C
1-10 Employees
2020
Key takeaway
BioShield Life Sciences is dedicated to establishing advanced development and manufacturing capabilities for next-generation biological therapies and vaccines in Latin America. Their focus on creating a state-of-the-art Contract Development and Manufacturing Organization (CDMO) positions them to enhance the region's capacity to produce innovative therapies, including CAR-T cell therapies.
Reference
Core business
About
BioShield Mission: To create world-class development and manufacturing capabilities for advanced biological therapies and vaccines. To empower Latin America (and the southern hemisphere) to combat current and future diseases, biological threats and pandemics.
Medison Pharma
Israelândia, Brazil
C
- Employees
1996
Key takeaway
Medison is a global pharmaceutical company dedicated to providing access to highly innovative therapies, emphasizing their mission to save lives by bridging market access gaps. They actively seek and facilitate faster access to breakthrough treatments for patients in international markets.
Reference
Core business
Medison Pharma - Always Ahead - Medison
Medison is a global pharma company focused on providing access to highly innovative therapies in international markets
Raggi-X
São Paulo, Brazil
C
1001-5000 Employees
2007
Key takeaway
Raggi-X is a leading provider of security screening systems, specializing in maintenance and service for advanced technology used in airports and secure facilities. Their commitment to high-quality solutions and experienced technicians ensures operational efficiency and reliability in security screening.
Reference
Core business
Company – Raggi-X
Decell Technologies Ltd.
Israelândia, Brazil
C
11-50 Employees
2000
Key takeaway
Decell Technologies Ltd. specializes in providing accurate, real-time traffic information through innovative technology and data analysis. Their mission highlights a commitment to delivering high-quality information, which may indirectly relate to advancements in medical technologies like CAR-T cell therapy.
Reference
Product
Decell Technologies
Light Capital Group
São Paulo, Brazil
C
11-50 Employees
-
Key takeaway
Light Capital Group is a global tech-focused investment firm with a team that has extensive experience in technology and venture capital.
Reference
Core business
Light Capital Group
Light Capital Group is a global tech-focused investment firm. Our team has extensive entrepreneurial, technology, venture & capital markets experience, creating billions in equity value.
Bionovis
Valinhos, Brazil
C
51-100 Employees
2012
Key takeaway
Bionovis is a pioneering Brazilian biopharmaceutical company focused on innovating and expanding its portfolio of complex biologics, which includes a commitment to research and development in high-quality biopharmaceuticals. With over 25 years of experience in biotechnology and immunology, Bionovis aims to improve patient lives through advanced therapies and innovative solutions.
Reference
Core business
Home - Bionovis
Empresa pioneira na produção de medicamentos biotecnológicosTemos como propósito melhorar a vida dos pacientes com o uso de alta tecnologia, inovação e ciência de ponta.Acesso àmedicamentosde alta complexidade para toda a população.InovaçãoProspecção de produtos e recursos científicos para licenciamento e transferência tecnológica de medicamentos inovadores e biossimilares. Previous Next Empresa pioneira na produção de medicamentos […]
Technologies which have been searched by others and may be interesting for you:
When exploring the CAR-T cell therapy industry in Brazil, several key factors should be taken into account. First, it is essential to understand the regulatory landscape, as the Brazilian Health Regulatory Agency (ANVISA) oversees the approval and commercialization of CAR-T therapies. Navigating these regulations can be complex due to the evolving nature of gene therapies and the need for compliance with both local and international standards. The competitive landscape features a mix of established pharmaceutical companies and emerging biotech firms, each vying for market share in a growing sector. Potential investors and researchers should evaluate partnerships and collaborations that can enhance innovation and broaden access to CAR-T therapies. Additionally, Brazil presents unique challenges such as healthcare infrastructure disparities and regional variations in access to advanced treatments, which can affect patient enrollment in clinical trials. However, the country also offers significant opportunities due to its large patient population and increasing investments in biotechnology. Environmental concerns related to the production and disposal of biological materials are also pertinent, necessitating adherence to sustainable practices. Lastly, understanding the global market relevance is crucial, as Brazil is positioning itself as a key player in Latin America for CAR-T therapies, attracting both domestic and international investment to drive research and development in this transformative field.
Some interesting numbers and facts about your company results for CAR-T Cell Therapy
| Country with most fitting companies | Brazil |
| Amount of fitting manufacturers | 14 |
| Amount of suitable service providers | 6 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1996 |
| Youngest suiting company | 2020 |
Some interesting questions that has been asked about the results you have just received for CAR-T Cell Therapy
What are related technologies to CAR-T Cell Therapy?
Based on our calculations related technologies to CAR-T Cell Therapy are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on CAR-T Cell Therapy?
The most represented industries which are working in CAR-T Cell Therapy are IT, Software and Services, Biotechnology, Healthcare, Consulting, Logistics, Supply Chain and Transportation
How does ensun find these CAR-T Cell Therapy Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.